[HTML][HTML] A phase II study of erlotinib as initial treatment for patients with stage IIIB-IV non-small cell lung cancer
W Akerley, KM Boucher, JS Bentz, K Arbogast… - Journal of Thoracic …, 2009 - Elsevier
Introduction: Erlotinib improves survival in patients with advanced non-small cell lung cancer
who have been previously treated with systemic chemotherapy. The current trial was …
who have been previously treated with systemic chemotherapy. The current trial was …
A phase II study of erlotinib as initial treatment for patients with stage IIIB-IV non-small cell lung cancer
W Akerley, KM Boucher, JS Bentz… - Journal of thoracic …, 2009 - pubmed.ncbi.nlm.nih.gov
Introduction Erlotinib improves survival in patients with advanced non-small cell lung cancer
who have been previously treated with systemic chemotherapy. The current trial was …
who have been previously treated with systemic chemotherapy. The current trial was …
[HTML][HTML] A Phase II Study of Erlotinib as Initial Treatment for Patients with Stage IIIB-IV Non-small Cell Lung Cancer
W Akerley, KM Boucher, JS Bentz, K Arbogast… - Journal of Thoracic …, 2009 - jto.org
Introduction: Erlotinib improves survival in patients with advanced non-small cell lung cancer
who have been previously treated with systemic chemotherapy. The current trial was …
who have been previously treated with systemic chemotherapy. The current trial was …
A phase II study of erlotinib as initial treatment for patients with stage IIIB-IV non-small cell lung cancer.
W Akerley, KM Boucher, JS Bentz… - Journal of Thoracic …, 2009 - europepmc.org
Methods Eligibility criteria included stage IIIB/IV or recurrent non-small cell lung cancer, no
prior chemotherapy for systemic disease, performance status= 0 to 1, no history of brain …
prior chemotherapy for systemic disease, performance status= 0 to 1, no history of brain …
[PDF][PDF] A Phase II Study of Erlotinib as Initial Treatment for Patients with Stage IIIB–IV Non-small Cell Lung Cancer
W Akerley, KM Boucher, JS Bentz… - Journal of Thoracic …, 2009 - scholar.archive.org
Results: Forty patients were accrued. The median age was 65 years, 35 had performance
status 1, 8 were never-smoker, and 23 were former smokers. Histologies were …
status 1, 8 were never-smoker, and 23 were former smokers. Histologies were …
[PDF][PDF] A Phase II Study of Erlotinib as Initial Treatment for Patients with Stage IIIB–IV Non-small Cell Lung Cancer
W Akerley, KM Boucher, JS Bentz, K Arbogast… - Journal of Thoracic …, 2009 - core.ac.uk
Results: Forty patients were accrued. The median age was 65 years, 35 had performance
status 1, 8 were never-smoker, and 23 were former smokers. Histologies were …
status 1, 8 were never-smoker, and 23 were former smokers. Histologies were …